Literature DB >> 31347415

Clinical and laboratory outcomes following total or partial splenectomy in patients with hereditary spherocytosis.

Serena I Tripodi1, Robert C Shamberger2,3, Matthew M Heeney3,4, Venée N Tubman3,4.   

Abstract

This study compared outcomes following total (TS) or partial splenectomy (PS) among patients with hereditary spherocytosis. Seventy-nine patients (TS = 33, PS = 46) were identified. The follow-up period was longer after PS (59.6 vs. 24.9 months, p < .001). Long-term adverse events occurred more frequently following PS (50% vs. 29%, p = .001). Anemia, jaundice, and fatigue recurred in six patients with PS, leading to five completion splenectomies. Hemoglobin was not different between PS and TS by 5 years post-procedure (12.3 vs. 13.4 g/dL, p = .25). Both PS and TS ameliorate symptoms and improve hematologic parameters. The rate of secondary surgery following PS should be considered when planning the initial surgical procedure.

Entities:  

Keywords:  Health outcomes; hereditary spherocytosis; splenectomy

Mesh:

Year:  2019        PMID: 31347415      PMCID: PMC6752974          DOI: 10.1080/08880018.2019.1637983

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  19 in total

Review 1.  Comparative effectiveness of different types of splenectomy for children with congenital hemolytic anemias.

Authors:  Henry E Rice; Shelley E Crary; Jacob C Langer; Alex R Kemper
Journal:  J Pediatr       Date:  2011-11-03       Impact factor: 4.406

2.  Delayed adverse vascular events after splenectomy in hereditary spherocytosis.

Authors:  R F Schilling; R E Gangnon; M I Traver
Journal:  J Thromb Haemost       Date:  2008-05-15       Impact factor: 5.824

3.  Long-term evaluation of the beneficial effect of subtotal splenectomy for management of hereditary spherocytosis.

Authors:  B Bader-Meunier; F Gauthier; F Archambaud; T Cynober; F Miélot; J P Dommergues; J Warszawski; N Mohandas; G Tchernia
Journal:  Blood       Date:  2001-01-15       Impact factor: 22.113

4.  Prevention and management of infections in patients without a spleen.

Authors:  R N Davidson; R A Wall
Journal:  Clin Microbiol Infect       Date:  2001-12       Impact factor: 8.067

5.  Guidelines for the diagnosis and management of hereditary spherocytosis--2011 update.

Authors:  Paula H B Bolton-Maggs; Jacob C Langer; Achille Iolascon; Paul Tittensor; May-Jean King
Journal:  Br J Haematol       Date:  2011-11-05       Impact factor: 6.998

6.  Partial splenectomy for hereditary spherocytosis: a multi-institutional review.

Authors:  Keely L Buesing; Elisabeth T Tracy; Colleen Kiernan; Aimee C Pastor; Laura D Cassidy; J Paul Scott; Russell E Ware; Andrew M Davidoff; Frederick J Rescorla; Jacob C Langer; Henry E Rice; Keith T Oldham
Journal:  J Pediatr Surg       Date:  2011-01       Impact factor: 2.545

7.  Risk of infection and death among post-splenectomy patients.

Authors:  N Bisharat; H Omari; I Lavi; R Raz
Journal:  J Infect       Date:  2001-10       Impact factor: 6.072

8.  [Malaria in splenectomized patients. Three fatal cases].

Authors:  J C Petithory; A Khelil; G Galéazzi; F Ardoin
Journal:  Presse Med       Date:  2005-04-09       Impact factor: 1.228

Review 9.  Red cell membrane: past, present, and future.

Authors:  Narla Mohandas; Patrick G Gallagher
Journal:  Blood       Date:  2008-11-15       Impact factor: 22.113

10.  Hereditary spherocytosis.

Authors:  Silverio Perrotta; Patrick G Gallagher; Narla Mohandas
Journal:  Lancet       Date:  2008-10-18       Impact factor: 79.321

View more
  1 in total

1.  Single-cell O2 exchange imaging shows that cytoplasmic diffusion is a dominant barrier to efficient gas transport in red blood cells.

Authors:  Sarah L Richardson; Alzbeta Hulikova; Melanie Proven; Ria Hipkiss; Magbor Akanni; Noémi B A Roy; Pawel Swietach
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-22       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.